Drug Shortage Report for THIAMIJECT INJECTION - LIQ IM IV 100MG/ML

Last updated on 2024-04-03 History
Report ID 213098
Drug Identification Number 02193221
Brand name THIAMIJECT INJECTION - LIQ IM IV 100MG/ML
Common or Proper name Thiamine Hydrochloride Injection USP
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) THIAMINE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5 x 10mL vial / fiole
ATC code A11DA
ATC description VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-12-19
Estimated end date 2024-06-03
Actual end date
Shortage status Actual shortage
Updated date 2024-04-03
Company comments Product on allocation starting mid-April 2024
Health Canada comments
Tier 3 Status Yes
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2024-04-03 French Compare
v13 2024-04-03 English Compare
v12 2024-02-29 English Compare
v11 2024-01-23 French Compare
v10 2024-01-23 English Compare
v9 2024-01-23 French Compare
v8 2024-01-23 English Compare
v7 2023-12-20 English Compare
v6 2023-12-19 French Compare
v5 2023-12-19 English Compare
v4 2023-12-19 French Compare
v3 2023-12-19 English Compare
v2 2023-12-12 French Compare
v1 2023-12-12 English Compare

Showing 1 to 14 of 14